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Patients with cystic fibrosis are often in a poor nutritional state and require dietary
supplementation to meet theenergy requirementsofan increased basal metabolic
rate.' As lung disease progresses, energy requirements increase further to meet
thestressofpulmonarysepsisand increased workof breathing.1-4 Dietarysupple-
mentation involves an overall increase in energy intake predominantly in the form
of carbohydrate, the most efficient energy substrate.5,6 We report the metabolic
and respiratory consequences of a glucose load, of equivalent energy value to
that usually given to such patients as an overnight supplementary feed by fine
bore nasogastric tube, in a hypoxic patient with cystic fibrosis who complained of
breathlessness and lethargy after meals.
CASEREPORT. A 28-year-old malewith cystic fibrosiswasreferred forassess-
ment of respiratory failure and cor pulmonale. Cystic fibrosis was diagnosed at
the age of five months because of repeated respiratory tract infection and failure
to thrive. Sweat sodium at that time was 78 mmol/l (normal < 40 mmol/l). He
remained well until the age of 26 when after a severe pulmonary exacerbation
he reported progressive shortness of breath.
At admission he was cyanosed, arterial oxygen tension (PaO2) 5-9 kPa with
hypercapnoea, arterial carbon dioxide tension (PaCO2) 6-85 kPa. There was
marked pulmonary disease with finger clubbing, and bilateral coarse crepitations
on examination. The Chrispin -Norman score based on changes on a chest radio -
graph was 21 points (O= no disease, 38= most severe).7 Sputum culture had
regularly grown Pseudomonas aeruginosa for more than five years during which
time he received intermittent courses of intravenous antibiotics. He was under-
nourished (47-1 kg; body mass index (BMI) 15-6 kg/m2); his Shwachman
score was 40 points indicating an overall poor clinical condition (100 points=
excellent; 40 or less = very severe).8 He had recently developed diabetes mellitus
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which was controlled with glibenclamide 10 mg daily. Hewas initially commenced
on a carbohydrate restricted diet, but due to weight loss the amount of carbo-
hydrate was increased to provide extra energy and improve his nutritional state.
Subsequently he reported symptoms of breathlessness, particularly after high
carbohydrate meals. To investigate this breathlessness, prior to beginning over-
night enteral feeding, he had a 75 gram glucose tolerance test (300 kcal)
following an overnight fast. The response of plasma glucose, the resting carbon
dioxide production (VCO2), oxygen uptake (V02), minute ventilation (VE) and
capillary blood gas tensions were determined. Respiratory gas exchange (Gould
Electronics) was measured for 10 minutes prior to each blood sample at 0, 60,
90, 120 and 180 minutes. Minute ventilation, oxygen uptake, carbon dioxide
production and respiratory exchange ratio (RER) were calculated from mixed
expired gas sampled every 20 seconds.9 The mean of measurement for the
second five minutes of each period is reported. The coefficient of variation for
each parameter (oxygen uptake, resting carbon dioxide production, minute
ventilation and respiratory exchange ratio) was between 4-8% for each five
minute period. The glucose tolerance test was repeated two days later while
breathing oxygen (fraction of oxygen in the inspired air (F102) = 28%) by face
mask to determine whether this further elevated arterial carbon dioxide tension.
The glucose load while breathing air caused a substantial increase in resting
oxygen uptake, carbon dioxide production and the respiratory exchange ratio
after two hours (Table). Minute ventilation and respiratory rate also increased.
Plasma glucose increased substantially at between one and two hours in parallel
with an increase in arterial carbon dioxide tension. When repeated, breathing
oxygen, a similar plasma glucose response occurred but with a higher arterial
carbon dioxide tension and the patient was more dyspnoeic. The glucose toler-
ance test was repeated five days later with 12 units of insulin given 20 minutes
prior to the glucose load. The rise in plasma glucose was less, increasing by 2 -5
mmol/l after 120 minutes and arterial carbon dioxide tension increased by 1-2
kPa. There was no difference in the blood gas responses when insulin was given
compared to when not.
DISCUSSION
We have demonstrated potentially deleterious effects of an oral glucose challenge
on resting metabolism and capillary blood gases in a diabetic patient with hypoxic
chronic obstructive lung disease due to cystic fibrosis. Patients with cystic fibrosis
are often markedly underweight and require nutritional support.1 5 Nutrition
becomes a particular problem as lung function deteriorates and patients develop
respiratory failure.' Such patients often require energy supplementation either by
mouth or by fine bore nasogastric tube feeding. Many supplements are high in
glucose and may represent a considerable metabolic load for patients already in
respiratory failure.'0" 1 In ambulatory patients with chronic obstructive pulmonary
disease, high carbohydrate diets increase dyspnoea and reduce exercise toler -
ance4 though these diets seem to have little effect on arterial carbon dioxide
tension.12 In patients with respiratory failure in an intensive care unit, intravenous
total parenteral nutrition with high glucose content feeds increases both carbon
dioxide production and arterial carbon dioxide tension.6 In our patient with
established respiratory failure the glucose load caused asimilar increase in carbon
dioxide production, arterial carbon dioxide tension and minute ventilation and
resulted in symptoms of dyspnoea and sleepiness.
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TABLE
Respiratory gas exchange, capillary blood gases and blood sugar responses to
75g glucose breathing room air and 28% oxygen
(Room air)
Oxygen uptake (\'O2)
(ml/min)
Carbon dioxide production
(VCO2) (ml/min)
Respiratory exchange ratio
(RER)
Minute ventilation (VE)
(I/mmin)
Respiratory rate (RR)
(b/min)
Plasma glucose (mmol/l)
Arterial oxygen tension
(PaO2) (kPa)
Arterial carbon dioxide
tension (PaCo2) (kPa)
pH
0
225
175
Minutes
60 90
235
187
228
181
0*79 0Q79 0-80 0-84 0-86
8*9
24
6*4
5-6
6-7
7.39
9.5
25
8*1
6-4
7 0
7-38
10-0 10-6 10*2
27
11-8
6-8
7.4
7-36
(28% 02)
Plasmaglucose(mmol/l) 5-0 11P4 14-4 16-2 16-1
Arterial oxygen tension
(PaO2) (kPa) 7.5 7 5 7-6 7 5 7.5
Arterial carbon dioxide
tensioh (PaCO2) (kPa) 6*8 7*7 7*7 7.4 7.5
pH 7-41 7-41 7-41 7-41 7 40
Room air + insulin 12u
Plasma glucose (mmol/1) 7-5 8-8 11 8 10.0 9-6
Arterial oxygen tension
(PaO2) (kPa) 5-0 5-2 5.4 5-4 5-5
Arterial carbon dioxide
tension(PaCO2)(kPa) 6-6 6-8 7.4 7-8 7.0
pH 7.45 7.45 7.44 7.40 7-42
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120
240
201
180
242
207
28
14-2
7 3
7 4
7 25
25
15*0
7*1
6-9
7*36
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A carbohydrate load, because of the high respiratory quotient (VC02/VO2) of
glucose (RQ=1) is known to increase carbon dioxide production relative to
oxygen uptake to a greater extent than fat (RQ = 0*7).13 The increase in carbon
dioxide production stimulates ventilatory receptors, increasing minute ventilation
to prevent arterial carbon dioxide tension from rising. In patients with severe
respiratory impairment the increase in ventilation may not be sufficient to remove
the excess CO2 produced and so, as in this case, an increase in arterial carbon
dioxide tension occurs. The observed increase in arterial oxygen tension after oral
glucose has been noted before and is most likely due to an increase in alveolar
ventilation.13
Diabetes mellitus occurs in 5-10% of adult patients with cystic fibrosis, and
impaired glucose tolerance is seen in up to 50%.14, 15 Diabetes is usually
controlled without much difficulty using oral hypoglycaemic agentsorsmall doses
of insulin. In our patient diabetes had not been a major problem and plasma
glucose levels were never greatly elevated. The glucose load after 12u of insulin
did not result in a substantial difference in arterial tension ofcarbon dioxide when
compared to glucose given alone. This suggests that diabetes did not contribute
to changes in blood gases, and the abnormal pulmonary function was primarily
responsible for the rise in arterial carbon dioxide tension. Although insulin did
not normalise the plasma glucose responses to the glucose load, it is possible that
the elevated glucose levels may have contributed to the patient's symptoms.
However, it might be expected that insulin would increase carbon dioxide
production by increasing the availability of intracellular glucose.
This report demonstrates the value ofassessing the blood gas response to an oral
glucose tolerance test which containsasimilar carbohydrate contenttocommerc-
ially available supplements for a single overnight tube feed. We had hoped to
provide overnight enteral feeding and oxygen therapy together, but in view of
the rise in arterial carbon dioxide tension following this combination and the
patient's increased symptoms, we decided to use a high fat feed. Reduction in the
proportion of carbohydrate in his diet in favour of fat and protein improved his
postprandial dyspnoea. This case illustrates the need to consider the metabolic
consequences of diet in patients with respiratory failure, particularly when
consideration is being given to intensive energy supplementation.
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